T1	Participants 78 111	advanced nasopharyngeal carcinoma
T2	Participants 180 256	Nasopharyngeal carcinoma (NPC) is a radiosensitive and chemosensitive tumor.
T3	Participants 417 557	From December 1993 to April 1999, 284 patients with 1992 American Joint Committee on Cancer stage III to IV (M0) NPC were randomly allocated
